<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Matsumoto A</submitter><funding>Japan Agency for Medical Research and Development</funding><funding>Mochida Memorial Foundation for Medical and Pharmaceutical Research</funding><funding>Uehara Memorial Foundation</funding><funding>Japan Society for the Promotion of Science</funding><pagination>102839</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC8326202</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>24(8)</volume><pubmed_abstract>Small extracellular vesicles (sEVs) are important mediators of intercellular communication with respect to diverse pathophysiological processes. Here, we determined novel phosphatidylserine (PS)-deficient sEV subpopulations as a major somatic cell-derived sEV subpopulation in blood because of long blood circulation half-life through escape from macrophage uptake. PS&lt;sup>(-)&lt;/sup>-sEVs were identified in various cultured cells as a minor population. However, as a result of rapid uptake of PS&lt;sup>(+)&lt;/sup>-sEVs by macrophages, circulating somatic cell-derived sEVs in the blood were found to be mainly PS&lt;sup>(-)&lt;/sup>-sEVs. These results suggest that endogenous PS&lt;sup>(-)&lt;/sup>-sEVs could indeed be the key player in sEV-mediated intercellular communication, a good target for sEV-based diagnosis, and a potent candidate for sEV-based drug delivery. Our findings bring a paradigm shift in the understanding of the biology and translational applications of sEVs.</pubmed_abstract><journal>iScience</journal><pubmed_title>Phosphatidylserine-deficient small extracellular vesicle is a major somatic cell-derived sEV subpopulation in blood.</pubmed_title><pmcid>PMC8326202</pmcid><funding_grant_id>JP20H04533</funding_grant_id><funding_grant_id>JP17K19390</funding_grant_id><funding_grant_id>JP18H02562</funding_grant_id><funding_grant_id>19ak0101120h0001</funding_grant_id><funding_grant_id>20ak0101120h0002</funding_grant_id><funding_grant_id>17fk0210104h0001</funding_grant_id><pubmed_authors>Nakagawa N</pubmed_authors><pubmed_authors>Matsumoto A</pubmed_authors><pubmed_authors>Kitamura S</pubmed_authors><pubmed_authors>Ishihama Y</pubmed_authors><pubmed_authors>Takakura Y</pubmed_authors><pubmed_authors>Ogata K</pubmed_authors><pubmed_authors>Takahashi Y</pubmed_authors><pubmed_authors>Yamamoto A</pubmed_authors></additional><is_claimable>false</is_claimable><name>Phosphatidylserine-deficient small extracellular vesicle is a major somatic cell-derived sEV subpopulation in blood.</name><description>Small extracellular vesicles (sEVs) are important mediators of intercellular communication with respect to diverse pathophysiological processes. Here, we determined novel phosphatidylserine (PS)-deficient sEV subpopulations as a major somatic cell-derived sEV subpopulation in blood because of long blood circulation half-life through escape from macrophage uptake. PS&lt;sup>(-)&lt;/sup>-sEVs were identified in various cultured cells as a minor population. However, as a result of rapid uptake of PS&lt;sup>(+)&lt;/sup>-sEVs by macrophages, circulating somatic cell-derived sEVs in the blood were found to be mainly PS&lt;sup>(-)&lt;/sup>-sEVs. These results suggest that endogenous PS&lt;sup>(-)&lt;/sup>-sEVs could indeed be the key player in sEV-mediated intercellular communication, a good target for sEV-based diagnosis, and a potent candidate for sEV-based drug delivery. Our findings bring a paradigm shift in the understanding of the biology and translational applications of sEVs.</description><dates><release>2021-01-01T00:00:00Z</release><publication>2021 Aug</publication><modification>2024-11-21T07:36:18.566Z</modification><creation>2022-02-11T05:25:51.924Z</creation></dates><accession>S-EPMC8326202</accession><cross_references><pubmed>34368655</pubmed><doi>10.1016/j.isci.2021.102839</doi></cross_references></HashMap>